Compare Stocks

→ Move Your Money Before May 1 (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRX Adhera Therapeutics	$0.01	$0.01	$0.01 ▼ $0.60	$87K	-0.15	112,918 shs	N/A
CAPS Capstone	$5.20	$5.20	$4.90 ▼ $20.00	$411K	133.95	N/A	N/A
ETST Earth Science Tech	$0.06	$0.07	$0.00 ▼ $0.12	$18.29M	1.77	66,422 shs	26,350 shs
WWHC W World	$0.80	$0.80	$0.80 ▼ $0.80	N/A	0.7	N/A	N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRX Adhera Therapeutics	-0.13%	+24.83%	-37.58%	-50.07%	-97.74%
CAPS Capstone	0.00%	0.00%	0.00%	0.00%	-85.95%
ETST Earth Science Tech	0.00%	-13.24%	-10.61%	-26.25%	+84.38%
WWHC W World	0.00%	0.00%	0.00%	0.00%	-20.00%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATRX Adhera Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CAPS Capstone	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ETST Earth Science Tech	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WWHC W World	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRX Adhera Therapeutics	N/A	N/A	N/A	N/A
CAPS Capstone	N/A	N/A	N/A	N/A
ETST Earth Science Tech	N/A	N/A	N/A	N/A
WWHC W World	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRX Adhera Therapeutics	N/A	N/A	N/A	N/A	($7.02) per share	N/A
CAPS Capstone	N/A	N/A	N/A	N/A	N/A	N/A
ETST Earth Science Tech	$50K	365.78	N/A	N/A	N/A	∞
WWHC W World	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRX Adhera Therapeutics	-$2.11M	-$1.15	N/A	∞	N/A	N/A	N/A	-5,805.73%	N/A
CAPS Capstone	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ETST Earth Science Tech	-$370K	N/A	0.00	∞	N/A	5.77%	20.61%	11.73%	N/A
WWHC W World	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRX Adhera Therapeutics	N/A	N/A	N/A	N/A	N/A
CAPS Capstone	N/A	N/A	N/A	N/A	N/A
ETST Earth Science Tech	N/A	N/A	N/A	N/A	N/A
WWHC W World	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRX Adhera Therapeutics	N/A	N/A	N/A
CAPS Capstone	N/A	N/A	N/A
ETST Earth Science Tech	0.10	0.87	0.39
WWHC W World	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ATRX Adhera Therapeutics	N/A
CAPS Capstone	2.55%
ETST Earth Science Tech	N/A
WWHC W World	N/A

Insider Ownership

Company	Insider Ownership
ATRX Adhera Therapeutics	28.20%
CAPS Capstone	42.80%
ETST Earth Science Tech	24.90%
WWHC W World	61.10%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRX Adhera Therapeutics	2	11.63 million	8.35 million	Not Optionable
CAPS Capstone	52	79,000	N/A	Not Optionable
ETST Earth Science Tech	8	309.98 million	232.80 million	Not Optionable
WWHC W World	2	N/A	N/A	Not Optionable

WWHC, ETST, ATRX, and CAPS Headlines

Source	Headline
	Canada celebrates as Poulin lifts squad to golden glory at women’s worlds sportsnet.ca - September 1 at 2:49 AM
	2 Saskatchewan referees earn their stripes at Women’s World Hockey Championship globalnews.ca - August 31 at 9:48 PM
	Five storylines to watch as Canada, USA battle for gold at women’s worlds sportsnet.ca - August 31 at 4:47 PM
	Canada tops Switzerland, will meet U.S. in women’s world championship final sportsnet.ca - August 31 at 3:45 AM
	U.S. blanks Finland to advance to women’s world hockey championship final sportsnet.ca - August 30 at 10:45 PM
	Russia downs Germany at women’s world hockey championship sportsnet.ca - August 29 at 10:02 PM
	Canadian women’s team savours Olympic preparation after pandemic disruption sportsnet.ca - August 29 at 5:01 PM
	Switzerland rallies to stun ROC in women’s hockey worlds quarterfinals sportsnet.ca - August 28 at 5:24 PM
	Canadian women’s hockey team forward Turnbull turns page on disappointment sportsnet.ca - August 28 at 1:27 AM
	Czech Republic blanks Germany to win Group B at women’s worlds sportsnet.ca - August 25 at 11:15 PM
	Finland blanks Russia for first win of women’s world hockey championship sportsnet.ca - August 25 at 6:14 PM
	Poulin ‘doing well’ after leaving Canada’s win over Swiss with injury sportsnet.ca - August 25 at 1:32 AM
	IIHF Women’s World Championships - How to Watch on August 22 \| Channel, Stream, Time mlive.com - August 24 at 8:32 PM
	Germany, Czech Republic stay undefeated at women’s hockey worlds sportsnet.ca - August 24 at 1:49 AM
	IIHF expected to schedule another women’s world hockey championship in 2022 sportsnet.ca - August 23 at 3:43 PM
	Hilary Knight ties women’s world championship goal record as U.S. beats Finland sportsnet.ca - August 23 at 12:38 AM
	Sarah Fillier finds her footing with Canadian women’s hockey team sportsnet.ca - August 21 at 8:52 PM
	CONCACAF announces two new major women's soccer tournaments tsn.ca - August 21 at 10:43 AM
	U.S. shuts out Switzerland to open women's world hockey sportsnet.ca - August 21 at 5:39 AM
	Sting in action; Jericho, MJF finally meet in grudge match on TSN2 tsn.ca - August 20 at 6:45 AM
	Canucks sign F Dickinson to three-year deal tsn.ca - August 16 at 4:08 AM
	The Five Labours of Jericho continue on TSN2 tsn.ca - August 12 at 9:42 PM

Media Sentiment Over Time

Company Descriptions

Adhera Therapeutics

OTCMKTS:ATRX

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Capstone

OTCMKTS:CAPS

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone veneer sidings, hardscapes and related moisture management products, lath products, and fireplaces offered under the Instone and Northeast Masonry names for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC

Earth Science Tech

OTCMKTS:ETST

Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.

W World

OTCMKTS:WWHC

W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial